Epidermal Growth Factor Receptor Mutation Analysis EGFR Exon 18 19 20 21
Introduction
The Epidermal Growth Factor Receptor Mutation Analysis (EGFR Exon 18, 19, 20, 21) is a pivotal diagnostic test that plays a significant role in the management of certain cancers, particularly non-small cell lung cancer (NSCLC). This test detects specific mutations in the EGFR gene, which are essential for determining the most effective treatment plans for patients. By understanding these mutations, healthcare providers can tailor therapies that target these alterations, improving patient outcomes.
What the Test Measures
This test specifically measures mutations in the EGFR gene located in exons 18, 19, 20, and 21. These mutations can influence how cancer cells grow and respond to specific treatments. By analyzing tumor tissue, we can identify the presence of these mutations, which is critical for personalized cancer therapy.
Who Should Consider This Test
This test is recommended for:
- Patients diagnosed with non-small cell lung cancer (NSCLC).
- Individuals exhibiting symptoms such as persistent cough, unexplained weight loss, or difficulty breathing.
- Those with a family history of lung cancer or other risk factors.
- Patients considering targeted therapy options.
Benefits of Taking the Test
Undergoing the Epidermal Growth Factor Receptor Mutation Analysis offers numerous benefits:
- Enables personalized treatment plans based on genetic mutations.
- Increases the likelihood of successful treatment outcomes.
- Provides critical information for managing cancer effectively.
- Helps in making informed decisions regarding treatment options.
Understanding Your Results
Results from the EGFR mutation analysis will indicate whether specific mutations are present in the tumor tissue. A positive result may suggest eligibility for targeted therapies, while a negative result may lead to alternative treatment strategies. It is essential to discuss the results with your healthcare provider to understand the implications for your treatment plan.
Test Name and Price
| Discount Price | Regular Price |
|---|---|
| 21,000 KSh | 28,000 KSh |
Additional Information
The test has a turnaround time of 3-4 days and requires a sample of tumor tissue. It is performed using Sanger Sequencing, a reliable method for detecting genetic mutations. Please note that a doctor’s prescription is required for this test, except in cases of surgery, pregnancy, or travel plans abroad.
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, making it easy for you to access our services. To book the Epidermal Growth Factor Receptor Mutation Analysis (EGFR Exon 18, 19, 20, 21) or for more information, please call or WhatsApp us at +254711564616. Don’t wait; take the first step towards personalized cancer treatment today!
